The present work discloses, for the first time, the reduction of GlcNAc levels in the hippocampus of a murine model of DS supporting the notion that this phenomenon, by heavily affecting APP and tau post-translational modifications, might have an evident role in the pathological mechanisms mediating the progression of AD-like dementia in DS individuals. The gene discussed is MAPT; the disease is Alzheimer disease.